4950
H. Y. Choi, D. Y. Chi / Tetrahedron 60 (2004) 4945–4951
2-methyl-7-(piperidin-1-yl)quinoline-5,8-dione (7a, 22 mg,
0.08 mmol, 3%). See the analytical data in Ref. 10.
200 mg, 0.79 mmol) was dissolved in dichloromethane
(10 mL) and triethylamine (0.5 mL) then 2-methylaziridine
(0.19 mL) was added at rt. After stirring for 5 min, H2O
(100 mL) was added and was extracted with dichloro-
methane and dried by Na2SO4 and was concentrated in
vacuo. The residue was purified by flash column chroma-
tography (40% EtOAc/hexane) to give 7b (170 mg,
0.75 mmol, 94%) as a yellow solid: See detail data are in
Ref. 10. 2-Methyl-6-(2-methylaziridin-1-yl)quinoline-5,8-
4.2.2. 2,4-Dibromo-5-aminophenol (13).30 The title com-
pound was prepared by acetylation of 3-aminophenol,
followed by selective 2,4-dibromination and deacetylation.
4.2.3. 6,8-Dibromo-5-hydroxy-2-methylquinoline (14).30
Crotonaldehyde (1.5 mL) was added into the mixture of 2,4-
dibromo-5-aminophenol (13, 1.15 g, 4.31 mmol) and con-
centrated HCl (10 mL) and AcOH (10 mL), then the
reaction mixture was refluxed for 30 min. The reaction
mixture was neutralized by NaHCO3 and extracted by
EtOAc and was concentrated in vacuo. The residue was
purified by flash column chromatography (60% EtOAc/
1
dione (11b, 8 mg, 0.04 mmol, 5%): H NMR (400 MHz,
CDCl3) d 8.28 (d, J¼8.0 Hz, 1H), 7.49 (d, J¼8.0 Hz, 1H),
6.39 (s, 1H), 2.77 (s, 1H), 2.40–2.43 (m, 1H), 2.20–2.23
(m, 2H), 1.47 (d, J¼6.0 Hz, 3H); 13C NMR (100 MHz,
CDCl3) d 183.2, 181.3, 164.9, 157.1, 147.5, 134.5, 126.8,
126.3, 118.9, 36.3, 34.5, 25.2, 17.5; MS (ESI, positive) 229
(Mþþ1, 100). HRMS (EIþ) m/z Calcd for C13H12N2O2
(Mþ) 228.0899, found 228.0889.
1
hexane) to give 14 (691 mg, 2.18 mmol, 51%): H NMR
(200 MHz, CDCl3) d 9.07 (bs, 1H), 8.23 (d, J¼8.4 Hz, 1H),
7.74 (s, 1H), 7.05 (d, J¼8.8 Hz, 1H), 2.49 (s, 3H); 13C NMR
(50 MHz, CDCl3 þDMSO-d6) d 159.7, 149.0, 143.7, 134.3,
131.1, 121.5, 119.6, 113.1, 102.9, 24.8; MS (EI) 319 (Mþ),
317 (Mþ), 315 (Mþ), 156, 128, 101, 64, 51, 32 (100).
HRMS (EIþ) m/z Calcd for C10H7Br2NO (Mþ) 316.8874,
found 316.8894.
4.3.2. 7-Benzylamino-2-methylquinoline-5,8-dione (7c).
1H NMR (200 MHz, CDCl3) d 8.29 (d, J¼8.0 Hz, 1H), 7.50
(d, J¼8.0 Hz, 1H), 7.28–7.40 (m, 5H), 6.42 (bs, 1H), 5.80
(s, 1H), 4.41 (d, J¼6.0 Hz, 1H), 2.73 (s, 3H); 13C NMR
(50 MHz, CDCl3) d 182.0, 180.4, 163.0, 147.9, 146.1,
135.6, 134.5, 129.0, 128.4, 128.2, 128.1, 127.6, 100.9, 46.9,
29.6, 24.9; MS (EI) 278 (Mþ), 276, 261, 194, 174, 117, 91
(100), 77, 65, 51, 39. HRMS (EIþ) m/z Calcd for
C17H14N2O2 (Mþ) 278.1055, found 278.1059.
4.2.4. 5,8-Dihydroxy-2-methylquinoline (15).27 Croton-
aldehyde (11.84 g, 169 mmol, 1.3 equiv.) was added into
the mixture of 2,5-dimethoxyaniline (20 g, 130 mmol) and
concentrated HBr (150 mL), then the reaction mixture was
refluxed for 24 h and the reaction mixture was neutralized
by NaHCO3 and extracted by EtOAc and was concentrated
in vacuo. The residue was purified by flash column
chromatography (40% EtOAc/hexane) to give 15 (7.4 g,
42.3 mmol, 33%): 1H NMR (200 MHz, CDCl3 þDMSO-d6)
d 8.41 (d, J¼8.4 Hz, 1H), 7.26 (d, J¼8.4 Hz, 1H), 6.93 (d,
J¼8.2 Hz, 1H), 6.77 (d, J¼8.4 Hz, 1H), 2.70 (s, 3H); 13C
NMR (50 MHz, CDCl3 þDMSO-d6) d 156.6, 144.8, 144.1,
137.4, 131.3, 120.8, 118.0, 108.9, 107.9, 24.6; MS (EI) 175
(Mþ, 100), 146, 118, 87, 74, 52, 39. HRMS m/z (EIþ)
175.0635, Calcd for C10H9NO2 175.0633.
4.3.3. 6-Benzylamino-2-methylquinoline-5,8-dione (11c).
1H NMR (200 MHz, CDCl3) d 8.25 (d, J¼8.0 Hz, 1H),
7.27–7.45 (m, 6H), 6.20 (bs, 1H), 5.95 (s, 1H), 4.39 (d,
J¼5.4 Hz, 1H), 2.77 (s, 3H); 13C NMR (50 MHz, CDCl3) d
181.5, 181.3, 165.4, 148.5, 147.0, 135.4, 134.1, 128.8,
128.0, 127.5, 126.0, 125.0, 102.2, 46.7, 26.3; MS (EI)
278 (Mþ, 100), 261, 201, 187, 174, 117, 91, 77, 65. HRMS
(EIþ) m/z Calcd for C17H14N2O2 (Mþ) 278.1055, found
278.1056.
Compounds 12a, 12c-g, 7d-g.10 See detail data are in
Ref. 10.
4.2.5. 6-Bromo-2-methylquinoline-5,8-dione (2).26 Acetic
anhydride (2 mL) was added into the mixture of 5,8-
dihydroxy-2-methylquinoline (15, 1.0 g, 5.57 mmol) and
dichloromethane (40 mL) and THF (10 mL). After stirring
at rt for 5 min, NBS (1.7 g, 9.55 mmol, 1.68 equiv.) was
added and was stirred for 10 min and then H2O (200 mL)
including NaHCO3 (3 g) added and extracted by dichloro-
methane and was concentrated in vacuo. The residue was
purified by flash column chromatography (60% EtOAc/
4.3.4. 8-Acetoxy-5-hydroxy-2-methylquinoline (18).
Acetic anhydride (2.7 mL, 28.8 mmol, 0.9 equiv.) was
added into the mixture of 5,8-dihydroxy-2-methylquinoline
(15, 5.6 g, 32.0 mmol) and dichloromethane (50 mL). After
stirring at rt for 30 min, the reaction mixture was
concentrated in vacuo. The residue was purified by flash
column chromatography (40% EtOAc/hexane) to give 18
(4.71 g, 22.0 mmol, 69%): 1H NMR (200 MHz, CDCl3
þDMSO-d6) d 9.96 (s, 1H), 8.37 (d, J¼8.4 Hz, 1H), 7.19 (d,
J¼8.4 Hz, 1H), 7.10 (d, J¼8.6 Hz, 1H), 6.74 (d, J¼8.4 Hz,
1H), 2.61 (s, 3H), 2.34 (s, 3H); 13C NMR (50 MHz, CDCl3
þDMSO-d6) d 167.9, 156.9, 149.3, 138.8, 136.8, 129.3,
119.1, 118.9, 116.9, 104.7, 23.3, 18.7; MS (CI) 218 (Mþþ1,
100), 204, 176. Anal. Calcd for C12H11NO3: C, 66.35; H,
5.10; N, 6.45. Found: C, 65.98; H, 5.48; N, 6.28.
1
hexane) to give 2 (1.23 g, 4.89 mmol, 85.7%): H NMR
(200 MHz, CDCl3) d 8.39 (d, J¼8.4 Hz, 1H), 7.65 (s, 1H),
7.59 (d, J¼8.0 Hz, 1H), 2.80 (s, 3H); 13C NMR (50 MHz,
CDCl3 þDMSO-d6) d 178.6, 175.1, 163.3, 144.3, 137.8,
137.0, 133.3, 125.4, 123.7, 22.9.; MS (EI) 253 (Mþ, 100),
251 (Mþ), 225, 223, 197, 195, 144, 116, 89, 63, 53, 39.
Anal. Calcd for C10H6BrNO2: C, 47.65; H, 2.40; N, 5.56.
Found: C, 47.40; H, 2.55; N, 5.53.
4.3.5. 6-Bromo-2-methylquinoline-5,8-dione (2) from
4.3. General procedure for amination of 6-bromo-2-
methylquinoline-5,8-dione (2) at Table 1
8-acetoxy-5-hydroxy-2-methylquinoline
(5.47 g, 30.7 mmol, 2.47 equiv.) was added into the mixture
of 8-acetoxy-5-hydroxy-2-methylquinoline (2.69 g,
(18).
NBS
4.3.1. 2-Methyl-7-(2-methylaziridin-1-yl)quinoline-5,8-
dione (7b).10 6-Bromo-2-methylquinoline-5,8-dione (2,
12.4 mmol) and dichloromethane (70 mL). After stirring
at rt for 30 min, the solvent was removed in vacuo. The